By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AmextaFinanceAmextaFinance
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Notification Show More
Aa
AmextaFinanceAmextaFinance
Aa
  • Banking
  • Credit Cards
  • Loans
  • Dept Management
  • Mortgage
  • Markets
  • Investing
  • Small Business
  • Videos
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Follow US
AmextaFinance > Markets > Stocks > Thermo Fisher Scientific undervalued by 24%, intrinsic value estimated at $597
Stocks

Thermo Fisher Scientific undervalued by 24%, intrinsic value estimated at $597

News Room
Last updated: 2023/11/09 at 7:13 AM
By News Room
Share
3 Min Read
SHARE

© Reuters.

Thermo Fisher Scientific Inc. (NYSE:) appears to be undervalued by approximately 24%, based on a two-stage growth model and discounted cash flow (DCF) model that estimates its intrinsic value at $597 per share, according to an analysis published Today. The current share price of the company stands at $454, indicating a significant gap between the market price and the estimated intrinsic value.

The financial models used in the analysis project ten-year cash flows, accounting for both growing and shrinking free cash flow situations. They consider an initial high growth phase and a later stable growth phase. This discrepancy between the current share price and the estimated intrinsic value is larger than the analyst price target of $529.

This assessment suggests there could be potential for investors in Thermo Fisher Scientific, given the disparity between its market price and estimated intrinsic value. However, it’s important for investors to conduct their own due diligence as market conditions and company performance can change rapidly.

InvestingPro Insights

In addition to the potential undervaluation highlighted in the article, InvestingPro data and tips further underscore Thermo Fisher Scientific Inc.’s (NYSE:TMO) investment potential.

InvestingPro data shows that TMO’s management has been proactively buying back shares, a move that often indicates confidence in the company’s future performance. This is complemented by a strong earnings record that has allowed the company to continue dividend payments, even raising its dividend for 5 consecutive years. This is a clear sign of the company’s commitment to returning value to its shareholders.

However, it’s worth noting that there’s been a declining trend in earnings per share, and 18 analysts have revised their earnings predictions downwards for the upcoming period. This suggests potential headwinds in the short-term, but the company’s longstanding position as a prominent player in the Life Sciences Tools & Services industry, coupled with high returns on book equity, indicate a resilient business model.

InvestingPro tips also highlight that TMO’s stock generally trades with low price volatility, providing a degree of stability for investors. The company has also been profitable over the last twelve months, and analysts predict it will continue to be profitable this year.

These are just a few of the insights available on InvestingPro, which offers an extensive array of data and tips for numerous companies. For a deeper dive into TMO and other investment opportunities, consider exploring InvestingPro’s comprehensive suite of resources.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Read the full article here

News Room November 9, 2023 November 9, 2023
Share this Article
Facebook Twitter Copy Link Print
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Finance Weekly Newsletter

Join now for the latest news, tips, and analysis about personal finance, credit cards, dept management, and many more from our experts.
Join Now
Elon Musk wants to launch a new political party. Here’s why some people think it won’t work.

Watch full video on YouTube

Why Even High Earners Are Living Paycheck To Paycheck

Watch full video on YouTube

Bank of America: Higher Yielding Preferred Stock Is Still Attractive (NYSE:BAC)

This article was written byFollowThe Investment Doctor is a financial writer, highlighting…

“Invest in what you know.”

Watch full video on YouTube

‘All the banks were lying’: Tom Hayes on his decade-long battle for justice

The last time Tom Hayes had his picture taken at London’s Southwark…

- Advertisement -
Ad imageAd image

You Might Also Like

Stocks

CPS reports solid 2023 performance, eyes future growth By Investing.com

By News Room
Stocks

Niu Technologies faces mixed results in Q4 2023 By Investing.com

By News Room
Stocks

Exagen Inc. reports strong 2023 revenue growth By Investing.com

By News Room
Stocks

Legacy Housing reports mixed results amid sales decline By Investing.com

By News Room
Stocks

Harmony Biosciences exec sells over $383k in stock By Investing.com

By News Room
Stocks

Biofrontera posts record revenue and outlines growth plans By Investing.com

By News Room
Stocks

Granite Ridge CFO buys $31,000 in company stock By Investing.com

By News Room
Stocks

Coliseum Capital Management buys MasterCraft Boat shares worth over $3.2m By Investing.com

By News Room
Facebook Twitter Pinterest Youtube Instagram
Company
  • Privacy Policy
  • Terms & Conditions
  • Press Release
  • Contact
  • Advertisement
More Info
  • Newsletter
  • Market Data
  • Credit Cards
  • Videos

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

I have read and agree to the terms & conditions
Join Community

2023 © Indepta.com. All Rights Reserved.

YOUR EMAIL HAS BEEN CONFIRMED.
THANK YOU!

Welcome Back!

Sign in to your account

Lost your password?